KalVista Corp (KALV): Bozor qiymati
Eksklyuziv patentlar va yetim dori vositasi maqomi KalVista Pharmaceuticals (KALV) biznesini mustahkamlab, raqobatchilar uchun kirishning sezilarli to'sig'ini yaratadi. Kompaniya noyob patologiyalar uchun terapiyalarni takomillashtirishda maxsus ekspertlar bilan sinergiyadan foydalanadi. Bozor kapitalizatsiyasi 1.38 miqdorida bo'lgan GURU.Markets platformasidagi ushbu narxlar grafigi, minimal kapital xarajatlar bilan og'iz orqali qabul qilinadigan tabletkalarning global savdosiga o'tish potentsialini tasdiqlaydi.
KalVista Pharmaceuticals (KALV) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Umumiy qarzning kapitalga nisbati KalVista Pharmaceuticals|KALV - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati kalvista.com|KALV - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati KalVista Pharma|KALV - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi KalVista Pharmaceuticals|Tezkor likvidlik koeffitsiyenti kalvista.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
KALV - Sof foyda|Kelajakdagi foyda KalVista Pharmaceuticals|KALV - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori kalvista.com|KALV - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati KalVista Pharma|KALV - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda KalVista Pharmaceuticals|KALV - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi kalvista.com|KALV - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi KalVista Pharmaceuticals
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning fundamental tahlili:KALV (KalVista Pharmaceuticals Inc)
KalVista Pharmaceuticals (KALV) barqarorligi uning yagona oral preparatining muvaffaqiyatli tijoratlashtirilishi bilan bevosita bog'liq bo'lib, bu holat yuqori baholashning yagona mahsulotga bog'liqligini yuzaga keltirmoqda. Barcha aksiyalarning umumiy bozor qiymati hissiy buzilishlarsiz obyektiv biznes qiymatini aks ettiradi, bu esa investorlarga kompaniyaning kapitalizatsiya grafigidan foydalanib, aktivlarning haddan tashqari qiziganini o'z vaqtida aniqlash va ayiqlar sikli boshlanishidan oldin pozitsiyaga kirishdan qochish imkonini beradi.
Muhim raqobatchilar
Bozor qiymati Argenx ARGX|BNTX: Bozor kapitallashuvi|ABVX: Bozor bahosi|ADMA Biologics (ADMA) - Bozor bahosi|PTGX (Protagonist Therapeutics Inc) - Bozor bahosi|IMVT: Bozor qiymati|Bozor qiymati Kiniksa|Grifols Group - Bozor bahosi|Bozor kapitallashuvi ADPT|CLDX (Celldex Therapeutics) - Bozor qiymati|Bozor kapitallashuvi AUPH (auriniapharma.com)|Bozor kapitallashuvi BioCryst Pharmaceuticals, Inc. BCRX|VERA - Bozor qiymati|Bozor qiymati DNTH (Dianthus Corp)|pharvaris.com (PHVS) - Bozor qiymati|Bozor bahosi AbCellera Biologics Inc|TRML (tourmalinebio.com) - Bozor kapitallashuvi|Bozor kapitallashuvi Intrexon|Bozor bahosi PHAR (Pharming)|NKTR (Nektar) - Bozor qiymati|Bozor qiymati upstreambio.com UPB|Bozor kapitallashuvi zenasbio.com (ZBIO)|IMNM - Bozor qiymati|Gossamer Bio Inc (GOSS) - Bozor bahosi|Septerna Pharma (SEPN) - Bozor qiymati|Bozor bahosi Pieris Pharmaceuticals|Bozor bahosi SVRA|Bozor kapitallashuvi rigel.com|Bozor qiymati AnaptysBio Corp (ANAB)|Astria Therapeutics, Inc. - Bozor kapitallashuvi|Bozor kapitallashuvi ENGN (engene.com)|RAPT Therapeutics Inc. (RAPT) - Bozor qiymati|Aerovate Therapeutics Inc - Bozor kapitallashuvi|ACRS - Bozor kapitallashuvi|KYTX (Kyverna Therapeutics, Inc) - Bozor bahosi|TLSA - Bozor kapitallashuvi|CABA (Cabaletta Bio, Inc) - Bozor kapitallashuvi|Bozor kapitallashuvi VTYX (Ventyx Biosciences)|Bozor qiymati Theratechnologies Inc. (THTX)|Bozor qiymati AVTX (avalotx.com)|Bozor qiymati Eledon Pharmaceuticals, Inc ELDN|Bozor kapitallashuvi Agenus, Inc. AGEN|CLYM: Bozor bahosi|ZURA: Bozor qiymati|ATYR: Bozor kapitallashuvi|Bozor qiymati Adagene Inc (ADAG)|IMA (Ikena Oncology) - Bozor kapitallashuvi|Bozor kapitallashuvi Shattuck Labs|Bozor kapitallashuvi EQ|Bozor qiymati CNTB (Connect Biopharma Holdings Limited)|Bozor qiymati immunic-therapeutics.com IMUX|Bozor qiymati ATRA (Atara Biotherapeutics Inc)|IFRX: Bozor bahosi|X4 Pharmaceuticals, Inc. (XFOR) - Bozor bahosi|ACET: Bozor kapitallashuvi|CELU - Bozor kapitallashuvi|Bozor qiymati INmune Bio|Bozor qiymati Barinthus Biotherapeutics plc BRNS|Bozor kapitallashuvi KZR|SABS - Bozor qiymati|Akari Therapeutics Plc - Bozor bahosi|enlivex.com (ENLV) - Bozor qiymati|QTTB - Bozor qiymati|Bozor kapitallashuvi GeoVax Labs, Inc. GOVX|EDSA: Bozor kapitallashuvi|iBio Inc - Bozor qiymati|CARM (Carisma Therapeutics Inc.) - Bozor kapitallashuvi|XTL Biopharmaceuticals, Ltd. (XTLB) - Bozor kapitallashuvi|Bozor kapitallashuvi BOLT|HCWB (HCW Biologics) - Bozor qiymati|Bozor kapitallashuvi APVO (Aptevo Therapeutics, Inc.)|Bozor qiymati AIM|ADTX: Bozor bahosi|Bozor qiymati GRI (GRI Bio Corp)|XRTX: Bozor kapitallashuvi|Bozor kapitallashuvi HIND|Bozor qiymati Revelation Biosciences, Inc.|Bozor kapitallashuvi INDP (Indaptus Therapeutics, Inc.)|Bozor kapitallashuvi SCNI|CALI (CalciMedica Inc) - Bozor qiymati|Bozor kapitallashuvi AFMD (Affimed NV)|ALLK - Bozor bahosi|HOOKIPA Pharma Inc. - Bozor kapitallashuvi|Bozor qiymati IGMS (igmbio.com)|iTeos Pharma (ITOS) - Bozor qiymati|Ocean Bio - Bozor qiymati|TCBP (TC BioPharm (Holdings) Plc) - Bozor kapitallashuvi|Bozor kapitallashuvi Third Harmonic Bio, Inc.
